1.Nardosinone protects H9c2 cardiac cells from angiotensin II-induced hypertrophy.
Meng DU ; Kun HUANG ; Lu GAO ; Liu YANG ; Wen-shuo WANG ; Bo WANG ; Kai HUANG ; Dan HUANG
Journal of Huazhong University of Science and Technology (Medical Sciences) 2013;33(6):822-826
Pathological cardiac hypertrophy induced by angiotensin II (AngII) can subsequently give rise to heart failure, a leading cause of mortality. Nardosinone is a pharmacologically active compound extracted from the roots of Nardostachys chinensis, a well-known traditional Chinese medicine. In order to investigate the effects of nardosinone on AngII-induced cardiac cell hypertrophy and the related mechanisms, the myoblast cell line H9c2, derived from embryonic rat heart, was treated with nardosinone (25, 50, 100, and 200 μmol/L) or AngII (1 μmol/L). Then cell surface area and mRNA expression of classical markers of hypertrophy were detected. The related protein levels in PI3K/Akt/mTOR and MEK/ERK signaling pathways were examined by Western blotting. It was found that pretreatment with nardosinone could significantly inhibit the enlargement of cell surface area induced by AngII. The mRNA expression of ANP, BNP and β-MHC was obviously elevated in AngII-treated H9c2 cells, which could be effectively blocked by nardosinone at the concentration of 100 μmol/L. Further study revealed that the protective effects of nardosinone might be mediated by repressing the phosphorylation of related proteins in PI3K/Akt and MEK/ERK signaling pathways. It was suggested that the inhibitory effect of nardosinone on Ang II-induced hypertrophy in H9c2 cells might be mediated by targeting PI3K/Akt and MEK/ERK signaling pathways.
Angiotensin II
;
physiology
;
Animals
;
Cardiotonic Agents
;
pharmacology
;
Cell Line
;
Cell Size
;
drug effects
;
Hypertrophy
;
metabolism
;
pathology
;
MAP Kinase Signaling System
;
Myoblasts, Cardiac
;
cytology
;
drug effects
;
metabolism
;
Phosphatidylinositol 3-Kinases
;
genetics
;
metabolism
;
Proto-Oncogene Proteins c-akt
;
genetics
;
metabolism
;
RNA, Messenger
;
genetics
;
metabolism
;
Rats
;
Sesquiterpenes
;
pharmacology
;
TOR Serine-Threonine Kinases
;
genetics
;
metabolism
2.Effect of ERK1/2 signaling pathway on astragaloside IV protects H9c2 cells against H2O2-induced oxidative injury.
Yuan-yuan WANG ; Yang PENG ; Qi ZHANG ; Yan-na WU ; Jun-qiu SONG ; Yan-xia LIU
Chinese Journal of Applied Physiology 2011;27(3):363-367
OBJECTIVETo investigate whether Astragaloside IV(AST) protects H9c2 cells against H2O2-induced oxidative injury partly through ERK1/2 signaling pathway.
METHODSH9c2 cells oxidative injury was induced by 200 tmol/L H2O2 for 6 hours to establish the H2O2-induced injury model of H9c2 cells. The viability of H9c2 cells was detected using MTf method. Activity of lactate dehydrogenase(LDH), total-superoxide dismutase (T-SOD), manganese-superoxide dismutase (Mn-SOD) and content of MDA (malondialdehyde) in the culture medium were detected using colorimetric method. Western blot was performed to exam expression of p-ERK1/2 and ERK1/2 in H9c2 cells respectively.
RESULTSUnder 200 micromol/L H2O2 treatment for 6 hours, the vaibility of H9c2 cells was suitable for the following study. Compared with H2O2 group, the cell viability was increased significantly in AST10 + H2O2 and AST2O + H2O2 groups (P < 0.01). The activity of LDH in the culture medium was decreased significantly (P < 0.01). The activity of T-SOD and Mn-SOD was increased significantly (P < 0.01), the content of MDA was decreased significantly (P < 0.01). Treated with 10 mg/L or 20 mg/L of AST, expression of p-ERK1/2 in H9c2 cells injured from H2O2 was increased significantly (P < 0.01), when PD98059 (inhibitor of ERK1/2) was added, the effects of AST were cancelled.
CONCLUSIONAST protects H9c2 cells against H2O2-induced oxidative injury partly through ERK1/2 signaling pathway.
Animals ; Antioxidants ; pharmacology ; Cell Line ; Hydrogen Peroxide ; toxicity ; MAP Kinase Signaling System ; physiology ; Myoblasts, Cardiac ; drug effects ; metabolism ; pathology ; Oxidative Stress ; drug effects ; Protective Agents ; pharmacology ; Rats ; Saponins ; pharmacology ; Triterpenes ; pharmacology
3.Curcumin reduces cold storage-induced damage in human cardiac myoblasts.
Hadil ABUARQOUB ; Colin J GREEN ; Roberta FORESTI ; Roberto MOTTERLINI
Experimental & Molecular Medicine 2007;39(2):139-148
Curcumin is a polyphenolic compound possessing interesting anti-inflammatory and antioxidant properties and has the ability to induce the defensive protein heme oxygenase-1 (HO-1). The objective of this study was to investigate whether curcumin protects against cold storage-mediated damage of human adult atrial myoblast cells (Girardi cells) and to assess the potential involvement of HO-1 in this process. Girardi cells were exposed to either normothermic or hypothermic conditions in Celsior preservation solution in the presence or absence of curcumin. HO-1 protein expression and heme oxygenase activity as well as cellular damage were assessed after cold storage or cold storage followed by re-warming. In additional experiments, an inhibitor of heme oxygenase activity (tin protoporphyrin IX, micrometer) or siRNA for HO-1 were used to investigate the participation of HO-1 as a mediator of curcumin- induced effects. Treatment with curcumin produced a marked induction of cardiac HO-1 in normothermic condition but cells were less responsive to the polyphenolic compound at low temperature. Cold storage-induced damage was markedly reduced in the presence of curcumin and HO-1 contributed to some extent to this effect. Thus, curcumin added to Celsior preservation solution effectively prevents the damage caused by cold- storage; this effect involves the protective enzyme HO-1 but also other not yet identified mechanisms.
Cell Death/drug effects
;
Cell Survival/drug effects
;
Cells, Cultured
;
Cold Temperature
;
*Cryopreservation
;
Cryoprotective Agents/pharmacology
;
Curcumin/*pharmacology
;
Gene Expression Regulation, Enzymologic/drug effects
;
Heme Oxygenase-1/genetics/metabolism
;
Hemin/pharmacology
;
Humans
;
Hydrogen Peroxide/pharmacology
;
Myoblasts, Cardiac/*drug effects/*pathology
;
RNA, Messenger/genetics/metabolism

Result Analysis
Print
Save
E-mail